InvestorsHub Logo
Post# of 252503
Next 10
Followers 832
Posts 119984
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 240022

Monday, 05/22/2023 11:06:38 AM

Monday, May 22, 2023 11:06:38 AM

Post# of 252503
Tang Capital makes_unsolicited AVIR buyout offer@$5.75/sh+CVR—a_55%_premium_to_Friday’s_close:

https://www.sec.gov/Archives/edgar/data/1593899/000121465923007616/z519230sc13d.htm (scan to bottom)

Why does Tang want to acquire AVIR? Presumably for AVIR’s COVID drug, AT-527, such as it is. AT-527 is a polymerase inhibitor that is similar to an HCV drug BMY dropped several years ago due to toxicity. AVIR is conducting a phase-3 trial in high-risk COVID patients using a daily dose of 1100 mg (550mg BID); the trial listing is at: https://www.clinicaltrials.gov/ct2/show/NCT05629962 .

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.